Regional spread of an atypical ESBL-producing Escherichia coli ST131H89 clone among different human and environmental reservoirs in Western Switzerland
Issued Date
2024-02-01
Resource Type
ISSN
00664804
eISSN
10986596
Scopus ID
2-s2.0-85184868226
Pubmed ID
38169291
Journal Title
Antimicrobial Agents and Chemotherapy
Volume
68
Issue
2
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy Vol.68 No.2 (2024)
Suggested Citation
Martischang R., Seth-Smith H., Verschuuren T.D., Héquet D., Gaïa N., François P., Fluit A.C., Kluytmans J.A.J.W., Seiffert S.N., Tacconelli E., Cherkaoui A., Harbarth S., Egli A., Kohler P. Regional spread of an atypical ESBL-producing Escherichia coli ST131H89 clone among different human and environmental reservoirs in Western Switzerland. Antimicrobial Agents and Chemotherapy Vol.68 No.2 (2024). doi:10.1128/aac.00925-23 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/97287
Title
Regional spread of an atypical ESBL-producing Escherichia coli ST131H89 clone among different human and environmental reservoirs in Western Switzerland
Author's Affiliation
Mahidol Oxford Tropical Medicine Research Unit
University Medical Center Utrecht
Università degli Studi di Verona
Universitätsspital Basel
Universitat Basel
Kantonsspital St.Gallen
Eberhard Karls Universität Tübingen
Universität Zürich
Hôpitaux Universitaires de Genève
Unité Cantonale Hygiène
Centre for Laboratory Medicine
University Medical Center Utrecht
Università degli Studi di Verona
Universitätsspital Basel
Universitat Basel
Kantonsspital St.Gallen
Eberhard Karls Universität Tübingen
Universität Zürich
Hôpitaux Universitaires de Genève
Unité Cantonale Hygiène
Centre for Laboratory Medicine
Corresponding Author(s)
Other Contributor(s)
Abstract
We describe the inter-regional spread of a novel ESBL-producing Escherichia coli subclone (ST131H89) in long-term care facility residents, general population, and environmental water sources in Western Switzerland between 2017 and 2020. The study highlights the importance of molecular surveillance for tracking emerging antibiotic-resistant pathogens in healthcare and community settings.